Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Taro Pharmaceutical Industries Ltd (NYSE:TARO)

101.55
Delayed Data
As of Aug 21
 -0.34 / -0.33%
Today’s Change
92.28
Today|||52-Week Range
134.69
-3.53%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues228.8M220.4M196.4M161.3M
 
 
 
 
 
Cost of Goods Sold47.7M49.4M48.7M41.0M
 
 
 
 
 
Depreciation And Amortization3.7M3.7M3.8M3.8M
 
 
 
 
 
 
Operating ExpensesGross Income177.4M167.3M143.9M116.5M
 
 
 
 
 
General Expenses35.7M38.3M42.1M38.9M
 
 
 
 
 
Research And Development14.8M18.0M19.9M14.7M
 
 
 
 
 
Total Operating Expenses87.2M91.4M94.6M83.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income141.6M129.0M101.8M77.6M
 
 
 
 
 
Extraordinary Charge-76.0K0.00-92.0K0.00
 
 
 
Other Expenses18.0M31.5M-5.1M-17.5M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income159.5M160.5M100.3M64.6M
 
 
 
 
 
Income Taxes-35.6M-20.5M-17.3M-10.0M
 
 
 
 
 
Minority Interest-243.0K-94.0K-23.0K-58.0K
 
 
 
 
 
Discontinued Operations-76.0K-137.0K-38.0K-47.0K
 
 
 
 
 
Net Income123.7M139.8M83.0M54.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS41.3M41.0M40.6M40.5M
 
 
 
 
 
Shares To Calculate EPS Diluted41.3M41.0M40.6M40.5M
 
 
 
 
 
 
Earnings Per ShareEPS$3.00$3.42$2.05$1.35
 
 
 
 
 
EPS Diluted$2.99$3.41$2.05$1.35